Literature DB >> 26629105

Epidemiology and genotype distribution of high risk human papillomavirus in population of hospital opportunistic screening.

Ying-Qiao Liu1, Xin He2, Sha-Sha Xu2, Jiu-Xin Qu3, Yue Wang4, Xiao-Li Diao4, Jun Liu2, Shu-Zhen Wang2.   

Abstract

This study aimed to determine the prevalence of high-risk human papillomavirus (HR-HPV) in population of hospital opportunistic screening and to identify the correlation of prevalent genotypes and cervical cytological abnormalities. A cross-sectional study was employed between July 2013 and July 2014 in the Chaoyang hospital, in Beijing. Cervical samples were collected for the Type-specific HPV and the cervical cytological analyses in the population of hospital opportunistic screening. Total of 8975 samples from female patients aged 17-86 years were tested. Of these, 10.4% were infected by HR-HPV, the highest prevalence of HR-HPV in the youngest group and decreasing with aging (X(2)=19.68, P=0.02). Of these, 78.73% were single infections and 21.27% were multiple infections. Age-specific prevalence of multiple HPV exhibited a "U" shaped curve (X(2)=19.98, P=0.018). The most prevalent genotype is HPV 52, then descending order of frequency were HPV-58, 16, 39, 51, 56, 59, 18, 31, 33, 35, 68 and 45. 15.9% had an abnormal cytology in HR-HPV positive women, vs 4.13% in HR-HPV negative women. The prevalence of HR-HPV were 9.2%, 26.8%, 32%, 35.3% and 36.4% in normal cell, ASCUS, LSIL, ASC-H and HSIL, respectively (X(2)=234.67, P=0.000). Women with HPV 52, 16, 18, 58, 39, 51, 59, 56, 33, 31 infections related to the abnormal cytology, while the HPV68, 45, 35 didn't. The prevalent characteristic in population of the hospital opportunistic screening is similar to the population of cervical screen, But the most five prevalent genotype in rank are different .Women with HR-HPV infections were more likely to have the cervical abnormal cytology.

Entities:  

Keywords:  High risk human papillomavirus; cervical cytology; epidemiology; population of hospital opportunistic screening

Year:  2015        PMID: 26629105      PMCID: PMC4658994     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

Review 1.  Host and viral genetics and risk of cervical cancer: a review.

Authors:  Allan Hildesheim; Sophia S Wang
Journal:  Virus Res       Date:  2002-11       Impact factor: 3.303

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Cross-sectional study of genital carcinogenic HPV infections in Paramaribo, Suriname: prevalence and determinants in an ethnically diverse population of women in a pre-vaccination era.

Authors:  Daan T Geraets; Antoon W Grünberg; Jannie J van der Helm; Maarten F Schim van der Loeff; Koen D Quint; Leslie O A Sabajo; Henry J C de Vries
Journal:  Sex Transm Infect       Date:  2014-06-11       Impact factor: 3.519

5.  Human papillomavirus type-specific prevalence in women referred for colposcopic examination in Beijing.

Authors:  Xiurong Ding; Zhizhong Liu; Jianrong Su; Donghui Yan; Wei Sun; Zhaoying Zeng
Journal:  J Med Virol       Date:  2014-08-13       Impact factor: 2.327

6.  Human Papillomavirus (HPV) infection in women participating in cervical cancer screening from 2006 to 2010 in Shenzhen City, South China.

Authors:  Yue-Yun Wang; Li Li; Sheng Wei; Ji Peng; Shi-Xin Yuan; Jian-Sheng Xie; Zhi-Hua Liu
Journal:  Asian Pac J Cancer Prev       Date:  2013

7.  Human papillomavirus: prevalence and factors associated in women prisoners population from the Eastern Brazilian Amazon.

Authors:  Sylvia Regina Vasconcellos de Aguiar; Fabiola Elizabeth Villanova; Luisa Carício Martins; Milena Silva dos Santos; Juliana de Paula Maciel; Luiz Fábio Magno Falcão; Hellen Thais Fuzii; Juarez Antônio Simões Quaresma
Journal:  J Med Virol       Date:  2014-05-16       Impact factor: 2.327

8.  Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study.

Authors:  M Dai; Y P Bao; N Li; G M Clifford; S Vaccarella; P J F Snijders; R D Huang; L X Sun; C J L M Meijer; Y L Qiao; S Franceschi
Journal:  Br J Cancer       Date:  2006-06-13       Impact factor: 7.640

9.  A cross sectional study of HPV type prevalence according to age and cytology.

Authors:  Elena Argyri; Stefanos Papaspyridakos; Elpida Tsimplaki; Lina Michala; Evangelia Myriokefalitaki; Issidora Papassideri; Dimitra Daskalopoulou; Ioanna Tsiaoussi; George Magiakos; Efstathia Panotopoulou
Journal:  BMC Infect Dis       Date:  2013-01-30       Impact factor: 3.090

10.  High incidence of oncogenic HPV genotypes found in women from Southern Brazil.

Authors:  Ludmila G Entiauspe; Mariângela Silveira; Emily M Nunes; Suélen P Basgalupp; Dulce Stauffert; Odir A Dellagostin; Tiago Collares; Fabiana K Seixas
Journal:  Braz J Microbiol       Date:  2014-08-29       Impact factor: 2.476

View more
  1 in total

1.  Prevalence Oncogenic Human Papillomavirus in Cervical Cancer Patients in Riau Province Indonesia.

Authors:  Maya Savira; Donel Suhaimi; Andani Eka Putra; Yusrawati Yusrawati; Nur Indrawati Lipoeto
Journal:  Rep Biochem Mol Biol       Date:  2022-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.